Karine Dubé, DrPH

Research Assistant Professor Public Health Leadership Program

T:(919) 966-6617

karine_dube@med.unc.edu

MacGavran-Greenberg 4108

CB 7042

Chapel Hill, NC 27599

USA

Karine Dubé, DrPH, MPhil (Oxon) is a social scientist and an experienced research program manager. She has close to 15 years of experience in infectious diseases-related work, including Ebola and HIV prevention and cure research.

Karine previously served as a research program manager for the Collaboratory of AIDS Researchers for Eradication (CARE) at UNC-Chapel Hill. She also is the co-founder and co-leader of the CUREiculum (http://www.avac.org/cureiculum), a collaborative program aimed at making HIV cure science accessible to the community and the HIV research field.

Karine has extensive experience working in resource-limited settings and developing clinical research site capacity. She managed a pox-protein prime-boost HIV-1C vaccine cohort development program, two HIV-1C prospective incidence studies and a clinical research site capacity development effort in Maputo, Beira and Chókwè, Mozambique with the United States Military HIV Research Program, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and FHI 360 (from 2008–2013).

Karine also has served as a research and program analyst with amfAR, the Foundation for AIDS Research.

Honors and Awards

Arthur B. Holzworth Endowed Scholarship in Health Leadership
2015, University of North Carolina at Chapel Hill

Representative Courses

Critical Issues in Global Health (PUBH 711) | Syllabus

Introduction to Global Public Health (SPHG 700) | Syllabus

Global Health Ethics (PUBH 712) (Spring 2017) | Syllabus

Research Activities

- HIV
- Infectious Diseases
- Interdisciplinary Research


Key Publications

'We Need to Deploy Them Very Thoughtfully and Carefully’: Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States – A Qualitative Inquiry. Dubé K, Evans D, Dee L, Sylla L, Taylor J, Skinner A, Weiner BJ, Greene SB, Rennie S, Tucker JD. (2017). AIDS Research and Human Retroviruses.
View on ReachNC

Interrupting Antiretroviral Treatment in HIV Cure Research: Scientific and Ethical Considerations. Garner SA, Rennie S, Ananworanich J, Dubé K, Margolis DM, Sugarman J, Tressler R, Gilbertson A, Dawson L.  (2017). Journal of Virus Eradication, 3(2), 82-4.
View on ReachNC

‘Well, It’s the Risk of the Unknown… Right?’: A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States. Dubé K, Taylor J, Sylla L, Evans D, Dee L, Burton A, Willenberg L, Rennie S, Skinner A, Tucker JD, Weiner BJ, Greene SB.  (2017). PLoS One, 12(1).
View on ReachNC

Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the U.S. Dubé K, Evans D, Sylla L, Taylor J, Weiner BJ, Skinner A, Thirumurthy H, Tucker JD, Rennie S, Greene SB. (2017). Journal of Virus Eradication, 3.
View on ReachNC

Towards a Multi-Disciplinary HIV Cure Research Agenda: Integrating the Social Science with Biomedical and Clinical Research. Grossman CI, Ross AL, Auerbach JD, Ananworanich J, Dubé K, Tucker JD, Noseda V, Possas C, Rausch D.  (2016). Trends in Microbiology, 24(1), 5-11.
View on ReachNC

Participation in HIV Cure Research: A Scoping Review of the Proxy Literature and Implications for Future Research. Dubé K, Ramirez C, Handibode J, Taylor J, Skinner A, Greene SB, Tucker JD.  (2015). The Journal of Virus Eradication, 1.
View on ReachNC

Framing Expectations in Early HIV Cure Research. Dubé K, Henderson GE, Margolis DM.  (2014). Trends in Microbiology – Science and Society, 22(10), 547-9.
View on ReachNC

How Does the Timing of Antiretroviral Therapy Initiation in Acute Infected Affect HIV Reservoir? Ananworanich J, Dubé K, Chomont N.  (2015). Current Opinion in HIV/AIDS, 10(1), 18-28.
View on ReachNC

Willingness to Participate in Future HIV Prevention Trials in Beira, Mozambique. Meque I, Dubé K, Bierhuizen L, Zango A, Veldhuijzen N, Cumbe F, Feldblum PJ, Wijgert Jvd. (2014). African Journal of AIDS Research, 13(4), 393-8.
View on ReachNC

HIV Incidence in a Cohort of Women at Higher Risk in Beira, Mozambique: Prospective Study 2009 – 2012. Dubé K, Zango A, Wijgert Jvd, Meque I, Ferro JJ, Cumbe F, Chen PL, Ma S, Jolles E, Fumo A, Robb ML, Feldblum PJ. (2014). PLoS One, 9(1).
View on ReachNC

Ebola Virus RNA Detection in Semen More than Two Years after Resolution of Acute Ebola Virus Infection. Fischer WA II, Brown J, Wohl DA, Loftis AJ, Tozay S, Reeves E, Pewu K, Gorvego G, Quellie S, Cunningham CK, Merenbloom C, Napravnik S, Dubé K, Adjasoo D, Jones E, Bonarwolo K, Hoover D. (2017). Open Forum Infectious Diseases.
View on ReachNC

Validation of the Cepheid GeneXpert for Detecting Ebola Virus in Semen. Loftis AJ, Quellie S, Chason K, Sumo E, Toukolon M, Otieno Y, Ellerbrok H, Hobbs MM, Hoover D, Dube K, Wohl DA, Fischer WA II.  (2016). Journal of Infectious Diseases.
View on ReachNC

Education

DrPH, Public Health, University of North Carolina at Chapel Hill, 2016

MPhil, Development Studies / International Health, Oxford University, 2005

BA, International Studies / Global Health (Minor in Business Administration), University of North Carolina at Chapel Hill, 2003